Company / Assets per Share
Annovis Bio, Inc. Assets per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$1.49
FY2025
5-year range
$1.25 / $6.67
FY2021-FY2025
Trend
+12.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $1.25 to $1.49 over the past 2 years.
Based on SEC 10-K filings.
1.49 in FY2025 with a 5-year CAGR of -44.7%.
Improved from $1.25 to $1.49 over the past 2 years.
Assets per Share over time
Growth rates
- 3-Year CAGR
- -30.5%
- 5-Year CAGR
- -44.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, assets per share increased 12.6% year-over-year.
- Peak assets per share was recorded in FY2020.
- Lowest assets per share in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -9.28 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.49 | +12.6% |
| FY2024 | $1.32 | +5.9% |
| FY2023 | $1.25 | -71.9% |
| FY2022 | $4.45 | -33.4% |
| FY2021 | $6.67 | -76.8% |
| FY2020 | $28.73 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026